HOE BAY 793Alternative Names: BAY 793; HOE 793
Latest Information Update: 15 Sep 1994
At a glance
- Originator Aventis; Bayer
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections